Brachytherapy with concurrent Capecitabine in advanced cervical cancer
Phase 2
Recruiting
- Conditions
- Cervical cancer, FIGO stage IB-IVA.Malignant neoplasm of cervix uteri
- Registration Number
- IRCT20210306050600N1
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 35
Inclusion Criteria
definite diagnosis of cervical cancer in the pathological sample
histology of SCC or Adenocarcinoma
stage IB-IVA based on gynecologic examination and imaging, making these patients chemoradiotherapy candidates
no evidence of distant metastasis
adequate performance status ( ECOG =2)
Exclusion Criteria
not willing to enter the trial
uncontrolled comorbidities, like diabetes mellitus and hypertension
warfarin use
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method